Kaye Scholer Reps Novartis In $420M Elidel Sale
Law360 (April 7, 2011, 2:12 PM EDT) -- Novartis AG said Thursday it would sell its skin cream treatment Elidel to Swedish pharmaceutical company Meda AB for $420 million in cash as part of its plan to focus on...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
